Austin-Based Savara Gets $7.4 Million to Test New Treatment for Cystic …

Published March 23, 2013

Austin-based Savara gets .4 million to test new treatment for cystic …

Filed under: Texas Drug Treatment Centers

Savara said its drug, called AeroVanc, is the first inhaled antibiotic being developed for the treatment of a life-threatening pulmonary staph infection in cystic fibrosis patients. Investors in the funding round included the Tech Coast Angels, the …
Read more on Austin American-Statesman

Experimental immune-system therapy offers new hope for leukemia patients

Filed under: Texas Drug Treatment Centers

Adults with B cell acute lymphoblastic leukemia (B-ALL) have a dismal prognosis if the blood cancer relapses following treatment. A new experimental … The findings were published on March 20 in the journal Science Translational Medicine by …
Read more on eMaxHealth